OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
33 hedge funds and large institutions have $43.3M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-8
Holders Change %
-19.51%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
5
Reduced
12
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
$457K |
2 |
Millennium Management
New York
|
$158K |
3 |
UBS Group
Zurich,
Switzerland
|
$145K |
4 |
Barclays
London,
United Kingdom
|
$143K |
5 |
E
Ergoteles
New York
|
$112K |